-
公开(公告)号:US5100784A
公开(公告)日:1992-03-31
申请号:US16651
申请日:1987-02-19
IPC分类号: C07K14/76 , C07K14/00 , C07K14/765 , C07K19/00 , C12N15/00 , C12N15/09 , C12N15/14 , C12N15/62 , C12N15/70 , C12P21/02 , C12R1/19
CPC分类号: C12N15/70 , C07K14/765 , C07K2319/00 , C07K2319/02
摘要: Mature human serum albumin is produced from a human serum albumin produced by a microbiological route in the form of fused protein ("pseudo-pro-HSA") containing an N-terminal peptide elongation.
摘要翻译: 通过微生物途径产生的人血清白蛋白是以含有N-末端肽伸长的融合蛋白(“假原HSA”)形式产生的。
-
公开(公告)号:US08822417B2
公开(公告)日:2014-09-02
申请号:US13463944
申请日:2012-05-04
申请人: Jan Terje Andersen , Bjorn Dalhus , Inger Sandlie , Jason Cameron , Andrew Plumridge , Esben Peter Friis , Karen Delahay
发明人: Jan Terje Andersen , Bjorn Dalhus , Inger Sandlie , Jason Cameron , Andrew Plumridge , Esben Peter Friis , Karen Delahay
CPC分类号: C07K14/765 , C07K2319/00
摘要: Variants of a parent albumin having altered plasma half-life compared with a parent albumin are described. Fusion polypeptides and conjugates including the variant albumin are also described. Embodiments include, but are not limited to, a polypeptide which is a variant of albumin, including one or more alterations at one or more positions corresponding to 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119 and 120 in SEQ ID NO: 2.
摘要翻译: 描述了与亲本白蛋白相比具有改变的血浆半衰期的亲本白蛋白的变体。 还描述了融合多肽和包含变体白蛋白的缀合物。 实施方案包括但不限于作为白蛋白变体的多肽,包括一个或多个在104,105,106,107,108,109,110,111,112,113,118,106,101,101,113,118,101,101,111,113,118,118,118,118,118,118,118,118,118,118,118,118,118,118,118,118,118,11 114,115,116,117,118,119和120在SEQ ID NO:2中。
-
公开(公告)号:US20120322739A1
公开(公告)日:2012-12-20
申请号:US13463944
申请日:2012-05-04
申请人: Jan Terje Andersen , Bjorn Dalhus , Inger Sandlie , Jason Cameron , Andrew Plumridge , Esben Peter Friis , Karen Delahay
发明人: Jan Terje Andersen , Bjorn Dalhus , Inger Sandlie , Jason Cameron , Andrew Plumridge , Esben Peter Friis , Karen Delahay
IPC分类号: A61K38/38 , C12N15/62 , C12N15/14 , C12P21/02 , C12N15/63 , C12N1/19 , C12N5/10 , C07K14/765 , A61P7/00 , B82Y5/00
CPC分类号: C07K14/765 , C07K2319/00
摘要: The invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The invention also relates to fusion polypeptides and conjugates comprising said variant albumin.
摘要翻译: 本发明涉及与母体白蛋白相比具有改变的血浆半衰期的亲本白蛋白的变体。 本发明还涉及包含所述变体白蛋白的融合多肽和缀合物。
-
公开(公告)号:US08022186B2
公开(公告)日:2011-09-20
申请号:US11927139
申请日:2007-10-29
申请人: Joseph Sheffer , Thea Norman , Richard D. Dimarchi , Anna-Maria A. Hays Putnam , Feng Tian , Stephanie Chu , Denise Krawitz , Ho Sung Cho
发明人: Joseph Sheffer , Thea Norman , Richard D. Dimarchi , Anna-Maria A. Hays Putnam , Feng Tian , Stephanie Chu , Denise Krawitz , Ho Sung Cho
IPC分类号: A61K38/38 , C07K14/765 , C12N15/14
CPC分类号: C07K14/47 , A61K38/00 , C07K14/765 , C07K19/00 , C07K2319/00
摘要: Modified human plasma polypeptides or Fc and uses thereof are provided.
-
公开(公告)号:US08021875B2
公开(公告)日:2011-09-20
申请号:US10229786
申请日:2002-08-27
CPC分类号: C12N15/85 , C07K14/765 , C12N2830/30 , C12N2830/34 , C12N2830/42 , C12N2830/50 , C12N2830/85
摘要: The present invention relates to compositions and methods for increasing long term expression in vitro and in vivo, comprising sequences and gene expression cassettes that increase expression of genes to which they are operably linked.
摘要翻译: 本发明涉及用于在体外和体内增加长期表达的组合物和方法,其包含增加其可操作连接的基因表达的序列和基因表达盒。
-
公开(公告)号:US07482157B2
公开(公告)日:2009-01-27
申请号:US11022243
申请日:2004-12-23
申请人: Yi-Pei Chen , Li-Ling Liaw , Chun-Lin Wang , Chung-Tsai Lee , Ing-Er Hwang , Ching-Ping Tseng , Gwo-Fang Yuan
发明人: Yi-Pei Chen , Li-Ling Liaw , Chun-Lin Wang , Chung-Tsai Lee , Ing-Er Hwang , Ching-Ping Tseng , Gwo-Fang Yuan
CPC分类号: C12P7/62 , C07K14/39 , C12N15/52 , C12P17/06 , C12Y101/01088
摘要: Cholesterol inhibitor produced by Monascus, monacolin k, is a secondary metabolite of polyketides. The invention provides probes specific to monacolin k biosynthesis gene cluster. BAC clones having putative monacolin k gene cluster were screened from BAC (bacterial artificial chromosome) library, and sequencing and annotation were performed on these clones. The results show that 2 polyketide synthase (PKS) genes and 7 regulatory genes related to monacolin k synthesis were obtained. Full-length cDNAs of these genes were then obtained by RT-PCR and cloned to expression vectors for the expression of these genes.
摘要翻译: 由Monascus,monacolin k生产的胆固醇抑制剂是聚酮化合物的次级代谢产物。 本发明提供了针对莫纳可克生物合成基因簇的探针。 从BAC(细菌人造染色体)文库中筛选出具有推定的莫纳可林k基因簇的BAC克隆,对这些克隆进行测序和注释。 结果表明,获得了2个聚酮化合物合成酶(PKS)基因和7个与monacolin k合成相关的调控基因。 然后通过RT-PCR获得这些基因的全长cDNA,并克隆到用于表达这些基因的表达载体中。
-
公开(公告)号:US07094411B2
公开(公告)日:2006-08-22
申请号:US10204252
申请日:2001-02-16
申请人: Richard M. Kinney , Claire Y. H. Kinney , Duane J. Gubler , Siritorn Butrapet , Natth Bhamarapravati
发明人: Richard M. Kinney , Claire Y. H. Kinney , Duane J. Gubler , Siritorn Butrapet , Natth Bhamarapravati
IPC分类号: A61K39/12 , A61K35/00 , A61K39/295 , C07K14/18 , C12N15/63 , C12N15/11 , C12N15/14 , C12N15/09 , C12N15/10 , C07H21/02 , C07H21/04
CPC分类号: A61K39/12 , A61K39/295 , A61K2039/5254 , A61K2039/5256 , A61K2039/53 , A61K2039/70 , C07K14/005 , C12N7/00 , C12N2770/24121 , C12N2770/24122 , C12N2770/24134 , Y02A50/386 , Y02A50/388 , Y02A50/39 , Y02A50/394 , Y02A50/396
摘要: Chimeric flaviviruses that are avirulent and immunogenic are provided. The chimeric viruses are constructed to contain amino acid mutations in the nonstructural proteins of a flavivirus. Chimeric viruses containing the attenuation-mutated nonstructural genes of the virus are used as a backbone into which the structural protein genes of a second flavivirus strain are inserted. These chimeric viruses elicit pronounced immunogenicity yet lack the accompanying clinical symptoms of viral disease. The attenuated chimeric viruses are effective as immunogens or vaccines and may be combined in a pharmaceutical composition to confer simultaneous immunity against several strains of pathogenic flaviviruses.
-
公开(公告)号:US20050244409A1
公开(公告)日:2005-11-03
申请号:US11173071
申请日:2005-07-01
IPC分类号: C12N15/09 , A61K39/395 , A61K45/00 , A61P7/00 , A61P7/06 , A61P13/12 , C07K16/28 , C12N5/10 , C12N15/12 , C12N15/13 , C12N15/14 , C12P21/08 , C12N5/06
CPC分类号: C07K16/2863 , A61K2039/505 , C07K2317/24
摘要: Erythropoietin receptor agonist and antagonist antibodies and their use in enhancing erythropoiesis are disclosed.
摘要翻译: 公开了红细胞生成素受体激动剂和拮抗剂抗体及其在增强红细胞生成中的用途。
-
公开(公告)号:US06921664B2
公开(公告)日:2005-07-26
申请号:US10054295
申请日:2002-01-18
申请人: Thomas R. Cech , Joachim Lingner , Toru Nakamura , Karen B. Chapman , Gregg B. Morin , Calvin B. Harley , William H. Andrews
发明人: Thomas R. Cech , Joachim Lingner , Toru Nakamura , Karen B. Chapman , Gregg B. Morin , Calvin B. Harley , William H. Andrews
IPC分类号: A61K38/00 , A61K39/00 , A61K48/00 , C12N9/12 , C12N15/113 , C12N15/12 , C12N5/00 , C12N5/06 , C12N9/60 , C12N15/14
CPC分类号: C12N15/113 , A01K2217/05 , A61K38/00 , A61K39/00 , A61K48/00 , C07K2319/00 , C12N9/1241 , C12N9/1276 , C12N15/1137 , C12N2310/15 , C12N2310/315 , C12Q1/6895 , C12Y207/07049
摘要: The present invention is directed to expression vectors comprising a polynucleotide that encodes a human telomerase reverse transcriptase (hTRT) protein, variant, or fragment. The present invention is also directed to host cells that comprise expression vectors comprising a polynucleotide that encodes a hTRT protein variant, or fragment.
摘要翻译: 本发明涉及包含编码人端粒酶逆转录酶(hTRT)蛋白,变体或片段的多核苷酸的表达载体。 本发明还涉及包含表达载体的宿主细胞,其包含编码hTRT蛋白质变体或片段的多核苷酸。
-
公开(公告)号:US20050048471A1
公开(公告)日:2005-03-03
申请号:US10794774
申请日:2004-03-08
申请人: Jerome Becquart , Reinhard Fleer , Philippe Hirel , David Klatzmann , Didier Landais , Jean-Francois Mayaux , Patrice Yeh
发明人: Jerome Becquart , Reinhard Fleer , Philippe Hirel , David Klatzmann , Didier Landais , Jean-Francois Mayaux , Patrice Yeh
IPC分类号: C12N15/09 , A61K38/00 , A61K39/00 , A61K39/12 , A61K39/21 , A61P31/12 , A61P31/18 , A61P35/00 , C07K14/00 , C07K14/47 , C07K14/705 , C07K14/73 , C07K14/765 , C07K14/82 , C07K19/00 , C12N1/19 , C12N15/12 , C12N15/14 , C12N15/62 , C12N15/67 , C12N15/81 , C12P21/00 , C12P21/04 , C12R1/645 , C12Q1/70 , C07H21/04 , C07K14/74 , C12N15/86 , C12Q1/68
CPC分类号: C07K14/765 , A61K38/00 , C07K14/00 , C07K14/4716 , C07K14/70514 , C07K14/82 , C07K2319/00 , C07K2319/02 , C07K2319/31 , C07K2319/32 , C07K2319/73 , C12N15/62 , C12N15/67 , C12N15/815
摘要: Utilization of albumin as a stable plasma transporter with a therapeutic function that is derived from a membrane receptor. The present invention is exemplified by the description of new therapeutic agents that can be used in the treatment of Acquired Immunodeficiency Syndrome: hybrid macromolecules composed of albumin derivatives coupled to derivatives of the CD4 receptor having a normal or a higher affinity for the HIV-1 virus.
摘要翻译: 利用白蛋白作为具有衍生自膜受体的治疗功能的稳定血浆转运蛋白。 本发明通过描述可用于治疗获得性免疫缺陷综合征的新的治疗剂的例子:由与HIV-1病毒具有正常或更高亲和力的CD4受体的衍生物偶联的白蛋白衍生物组成的杂合大分子 。
-
-
-
-
-
-
-
-
-